
All News



Pharmaceutical Executive
Russia had been a country in flux-monetary crises, corruption scandals, oil surpluses, etc. But no multinational should be scared off by the market anymore, not with its economy on the verge of breaking out.



Pharmaceutical Executive
If high prices that lower access are attributable to a flawed R&D model, can industry embrace delivering better results at lower costs.

Pharmaceutical Executive
Pharm Exec's 2011 Emerging Leaders celebration convened Oct. 6 in New York.

Pharmaceutical Executive
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?

Invitation Application for Pharma and Biotech Industry Executives:

UPS Survey Unveils Healthcare Supply Chain Trends

Pharmaceutical Executive
Atsushi Nagahisa, President & CEO, RaQualia

Pharmaceutical Executive
Jean-Claude Labrune, Chairman & CEO, Cegedim Group

Pharmaceutical Executive
Harvey Bale, Jr., MD, former Director-General, IFPMA

Pharmaceutical Executive
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint

Pharmaceutical Executive
Jane Henney, MD, Former FDA Commissioner

Pharmaceutical Executive
P. Roy Vagelos, MD, Chairman Emeritus, Merck

Pharmaceutical Executive
Francis Collins, MD, PhD, Director, National Institutes of Health

Pharmaceutical Executive
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech

Pharmaceutical Executive
Martin Wygod, Chairman, WebMD

Pharmaceutical Executive
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group

Pharmaceutical Executive
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine

Pharmaceutical Executive
Sir Martin Sorrell, CEO, WPP

Pharmaceutical Executive
Fernand Sauer, First Director General, European Medicines Agency

Pharmaceutical Executive
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.

Pharmaceutical Executive
Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.

Pharmaceutical Executive
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation

Pharmaceutical Executive
Three Decades of Politics and Pop Culture ... on Drugs


Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.